ERBB2 and breast carcinoma: There was no significant association of ALDH1(+) cases with any other parameters, such as patients’ age, tumor stage, tumor grade or breast cancer subtype, though there were relatively higher ALDH1(+) cases in HER2 (59%) and triple negative (55%) subtypes compared to luminal subtypes (41%).